$HTBX“It’s completely simple,” said Daunert. “It can be used either in a physician’s office or by health care workers in remote rural locations where there are no hospitals or clinics. But in the process we are also developing a platform that can be customized for different viruses — it’s not just for Zika — because different ones are going to keep popping up.” After completing the test development, which is still several months away, Watkins and Daunert will apply for a patent and begin seeking investors to bring it to market.
  • 1
  • 1